Suppr超能文献

[本月药物。伐尼克兰(畅沛)]

[Drug of the month. Varenicline (Champix)].

作者信息

Vandemergel X

机构信息

Service de Médecine Interne Générale et Centre d'Aide aux Fumeurs, CHR Nivelles-Tubize, Belgique.

出版信息

Rev Med Liege. 2007 Feb;62(2):122-4.

Abstract

Smoking is responsible for 20,000 premature deaths per year in Belgium. Paradoxically, few drugs are efficient to induce tobacco cessation and to decrease relapse. Until a few weeks ago nicotin replacement therapy and bupropion only were validated in this indication. Varenicline (Champix), a partial agonist of nicotinic receptors, is a novel type of drugs currently also accepted for sale for smoking cessation. This article dwells on recent publications about efficacy of varenicline. Position, side-effects and advantages of the drug are discussed.

摘要

在比利时,吸烟每年导致2万例过早死亡。矛盾的是,很少有药物能有效帮助戒烟并减少复吸。直到几周前,只有尼古丁替代疗法和安非他酮在这一适应症上得到验证。伐尼克兰(畅沛)是一种烟碱样受体部分激动剂,是目前也被批准用于戒烟销售的新型药物。本文详述了关于伐尼克兰疗效的近期出版物。讨论了该药物的地位、副作用及优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验